期刊文献+

来氟米特治疗中老年类风湿关节炎的疗效评价 被引量:1

Effect of leflunomide on senile rheumatoid arthritis
下载PDF
导出
摘要 目的 探讨来氟米特 (LF)治疗中老年类风湿关节炎的疗效和不良反应。  方法  选择 2 3例中老年类风湿关节炎患者 ,用LF 2 0mg·d-1口服 ,疗程为 12周 ,比较 6周和 12周的疗效。  结果  治疗 6周时病情明显进步 3例 ,进步 3例 ,改善 10例 ,总有效率为 69 6%。 12周时明显进步 5例 ,进步 9例 ,改善 6例 ,总有效率为87%。 5例发生不良反应 (2 1 7% ) ,表现为皮疹、白细胞下降、脱发、瘙痒 ,2例停药 (撤药率 8 7% )。无严重不良反应。  结论  LF治疗老年类风湿关节炎有效且相对安全。 Objective To investigate efficacy and side effect of leflunomide in treatment of rheumatoid arthritis. Methods Twenty three old patients with rheumatoid arthritis were treated with leflunomide(oral 20 mg·d -1 ).The treatment duration was 12 weeks.The 6 week and 12 week results were compared. Results After 6 weeks,3 patients got obvious progression,3 got progression,10 got improvement.The total effective rate was 69 6%.By the end of treatment duration,5 cases got obvious progression,9 got progression,6 got improvement.The effective rate was 87%.Five patients had appeared side effects(21 7%) including skin rash,leukopenia,alopecia and itching.Two cases withdrew from trial.There were no severe side effects in all patients. Conclusion Leflunomide is not only effective but also safe drug to treat aged rheumatoid arthritis.
出处 《实用老年医学》 CAS 2002年第5期261-263,共3页 Practical Geriatrics
关键词 类风湿关节炎 来氟米特 不良反应 治疗 疗效评价 Rheumatoid Arthritis Leflunomide Side effect
  • 相关文献

参考文献6

  • 1Manna SK,Mukhopadhyay A,Aggarwal BB,et al.Leflunomide suppresses TNF-induced cellular responses:effects on NK-kappa B,activator protein-1,c-jun N-terminal protein kinase,and apoptosis[J].J Immunol,2000,165(10):5962 被引量:1
  • 2Cohen S,Cannon GW,Schiff M,et al.Two-year,blinded,randomized,controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate.Utilization of leflunomide in the Treatment of Rheumatoid Arthritis Trial Inversigator Group[J].Arthritis Rheum,2001,44(9):1984 被引量:1
  • 3Felson DT,Anderson JJ,Boers M,et al.American College of Rheumatology Preliminary definition of improvement in rheumatoid arthritis[J].Arthritis Rheum,1995,38(6):727 被引量:1
  • 4帅宗文,李向培,徐建华,厉小梅.来氟米特与甲氨喋呤对照治疗类风湿关节炎160例[J].中国新药杂志,2001,10(4):292-294. 被引量:2
  • 5Sharp J,Strand V,Leung H,et al.Treatment with leflunomide slows radiographic progression of rheumatoid arthritis:results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis[J].Arthritis Rheum,2000,43(5):495 被引量:1
  • 6Weinblatl ME,Kremer JM,loblyn JS,et al.Pharmacokinetics,safety and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis[J].Arthritis Rheum,1999,42:1322 被引量:1

二级参考文献9

  • 1[1]Barlett RR,Anagnostopulos H,Zielinski T,et al.Effects of leflunomide on immune responses and models of inflammation[J].Springer Semin Immunopathal,1993,14(4)∶381-394. 被引量:1
  • 2[2]Mldenovic V,Domljan Z,Rozman B,et al.Safety and effectiveness of leflunomide in the treatment of patients with rheumatoid arthritis[J].Arthritis Rheum,1995,38(11)∶1596-1603. 被引量:1
  • 3[3]Smolen JS,Kalden JR,Scott DL,et al.Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis:a double-blind,randomised,multicentre trial.Lancet,1999,353(9149)∶259-266. 被引量:1
  • 4[4]Felson DT,Anderson JJ,Boers M,et al.American college of rheumatology preliminary definition of improvement in rheumatoid arthritis[J].Arthritis Rheumat,1995,38(6)∶727-735. 被引量:1
  • 5[5]Felsion DT,Anderson JJ,Lange MLM,et al.Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures,rather than twenty percent[J]Arthritis Rheumat,1998,41(9)∶1564-1570. 被引量:1
  • 6[6]Ruckemann K,Fairbanks LD,Carrey EA,et al.Leflunornide inhibits pyrimidme de novo synthesis in mitogen-stimulated T lymphooytes from healthy humans.J Biol Chem,1998,273(34)∶21682-21691. 被引量:1
  • 7[7]Chong ASF, Finnegan A,Jiang XL,et al.Leflunomide,a novel immunosupressive agent:the mechanism of inhibition of T cell proliferation[J].Transplantation,1993,55∶1361. 被引量:1
  • 8[8]Siemasko KF,Chong A,Williams JW,et al.Regulation of B cell function by the immunosupressive agent leflunomide[J].Transplantation,1996,619(4)∶635-642. 被引量:1
  • 9[9]Siemasko K,Chong AS,Jack HM,et al.Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgGl production.J Immunol,1998,160(4)∶1581-1588. 被引量:1

共引文献1

同被引文献4

  • 1Cohen S,Cannon G,Schiff M,et al.Two-year,blind,randomized,controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate:utilization of leflunomide in the treatment of rheumatoid arthritis trail investigator group.Arthritis Rheum,2001,44:1984-1992. 被引量:1
  • 2Kalder JR,Soott DL,Smolen JS,et al. Improve functional ability in patient with rheumatoid arthritis-longterm treatment with leflunomide versus sulfasalazine:European leflunomide study group. J Rheumatol, 2001,28:1983-1991. 被引量:1
  • 3栗占国.重视类风湿关节炎的规范化治疗[J].中华风湿病学杂志,2003,7(8):459-461. 被引量:13
  • 4张凤山,聂英坤,孙铀,李英楠,于慧敏,赵阴环,金晓明.来氟米特治疗狼疮肾炎疗效分析[J].中华风湿病学杂志,2004,8(2):73-76. 被引量:42

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部